Skip to main content
Caplight Logo









Shanghai BioEngine Sci-Tech Co., Ltd.

Shanghai BioEngine Sci-Tech Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://bioengine-global.com/

Last Round

Series C

May 15, 2023

Total Funding Raised

$42.93M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Shanghai BioEngine Sci-Tech Co., Ltd. is a biotechnology company that provides serum-free, chemically defined cell culture media and integrated technical services for the development and manufacturing of antibodies, vaccines, and cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

cell culture mediabioprocessingbiopharma supply chainchemically defined mediabiologics manufacturingCDMObioprocess optimizationcustom media developmentbiotech reagentsmedia formulationanimal-derived component-freeADCFbiotech R&Dbioprocess scale-uplab supplies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai BioEngine Sci-Tech Co., Ltd. Comparables

Compare Shanghai BioEngine Sci-Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai BioEngine Sci-Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai BasalMedia Technologies Co., Ltd.
89%
Shanghai Medium Bank Biotechnology
89%
ExCell Bio Group
87%

Shanghai BioEngine Sci-Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 15, 2023

Shanghai BioEngine Sci-Tech Co., Ltd. Investors

Notable investors and investment history

Shanghai BioEngine Sci-Tech Co., Ltd. investors
InvestorRounds
HM CapitalSeries C
Legend CapitalSeries B, Series C
Addor CapitalSeries B, Series C
Sunshine Riverhead Capital Investment Management Co., Ltd.Series C
建发新兴投资Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 86% MoM, reaching 1K.

  • May 15, 2026

    Monthly visitors increased 95% MoM.

Shanghai BioEngine Sci-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai BioEngine Sci-Tech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai BioEngine Sci-Tech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range19
Year Founded2014
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?